OBERIJE Cary: Doctor of Philosophy (Radiation Oncology) 2011, University of Maastricht, The Netherlands. Postdoctoral researcher, University of Maastricht (The Netherlands)
Date of birth: 1966, Brunssum, The Netherlands
SUMMARY: Cary Oberije is currently the head of the Virtual Trial Unit+. This new interdisciplinary initiative aims to improve and facilitate collection and (re)use of health care data, by applying innovative approaches including but not limited to artificial data creation, data augmentation and virtual clinical trials.
Cary started working at the MAASTRO Clinic datacenter as a statistical analyst and clinical researcher in 2002. In 2005, she obtained a Master of Science in Health Psychology (Open University, Heerlen). Next to the psychology study, she followed courses in biostatistics and epidemiology. In 2011 she defended her PhD thesis “Predicting outcome in lung cancer patients: Towards individualized treatment in radiotherapy”.
As a postdoctoral researcher, she was involved in a number of clinical research projects, that all focus on outcome prediction for cancer patients. She has expertise in radiation oncology, predictive modeling, and blood, imaging and genetic biomarkers.
Currently, she combines management of the Virtual Trial Unit+ with a research project that focuses on mitochondrial DNA as a prognostic factor for development of radiation-induced side effects. For this project she received a KWF grant in 2015. Her work until now resulted in more than 47 peer-reviewed publications.